{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:216239",
      "entity_text" : "sorafenib",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "chebi:CHEBI:26523",
      "entity_text" : "ROS",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Besides inhibition of tyrosine receptor signaling, induction of ROS in tumor cells also underlies the antitumor activity of sorafenib XREF_BIBR, XREF_BIBR, which prompted us to explore whether melatonin could significantly enhance the anti-leukemia activity of sorafenib though redox modification and achieve a synergistic therapeutic effects.",
  "reading_complete" : "2020-08-03T17:34:37Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:33:43Z",
  "trigger" : "underlies",
  "evidence" : [ "ROS in tumor cells also underlies the antitumor activity of sorafenib" ],
  "pmc_id" : "6587355",
  "score" : 0
}